153 related articles for article (PubMed ID: 6280730)
1. Inhibition of calmodulin-activated cyclic nucleotide phosphodiesterase: multiple binding-sites for tricyclic drugs on calmodulin.
Reynolds CH; Claxton PT
Biochem Pharmacol; 1982 Feb; 31(3):419-21. PubMed ID: 6280730
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
Ahluwalia GS; Rhoads AR
Biochem Pharmacol; 1982 Mar; 31(5):665-9. PubMed ID: 6177320
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
Ilien B; Ruckstuhl M; Landry Y
J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
[TBL] [Abstract][Full Text] [Related]
4. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE
Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of regucalcin on Ca2+/calmodulin-dependent cyclic AMP phosphodiesterase activity in rat kidney cytosol.
Yamaguchi M; Kurota H
Mol Cell Biochem; 1997 Dec; 177(1-2):209-14. PubMed ID: 9450664
[TBL] [Abstract][Full Text] [Related]
6. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
Donnelly TE; Barron B
Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of cyclic nucleotides and their analogs and various agents on cyclic GMP-specific and cyclic AMP-specific phosphodiesterases purified from guinea pig lung.
Davis CW; Kuo JF
Biochem Pharmacol; 1978 Jan; 27(1):89-95. PubMed ID: 202285
[No Abstract] [Full Text] [Related]
8. Effects of polyphloretin phosphate (PPP) and quinterenol of cyclic nucleotide phosphodiesterase activities.
Curtis-Prior PB; Chan YH
Pharmacol Res Commun; 1981 Apr; 13(4):331-7. PubMed ID: 6270700
[No Abstract] [Full Text] [Related]
9. Flavonoids are selective cyclic GMP phosphodiesterase inhibitors.
Ruckstuhl M; Beretz A; Anton R; Landry Y
Biochem Pharmacol; 1979; 28(4):535-8. PubMed ID: 218594
[No Abstract] [Full Text] [Related]
10. Inhibition of the different cyclic nucleotide phosphodiesterase isoforms separated from rat brain by flavonoid compounds.
Picq M; Dubois M; Prigent AF; Némoz G; Pacheco H
Biochem Int; 1989 Jan; 18(1):47-57. PubMed ID: 2541724
[TBL] [Abstract][Full Text] [Related]
11. Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships.
Van Inwegen RG; Salaman P; St Georgiev V; Weinryb I
Biochem Pharmacol; 1979 Apr; 28(8):1307-12. PubMed ID: 87199
[No Abstract] [Full Text] [Related]
12. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
13. Myofibrillar bound cyclic nucleotide phosphodiesterase in heart and skeletal muscle.
Worby A; Mensah LM; Murray KJ
Biochem Soc Trans; 1992 May; 20(2):129S. PubMed ID: 1327896
[No Abstract] [Full Text] [Related]
14. A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
Weishaar RE; Cain MH; Bristol JA
J Med Chem; 1985 May; 28(5):537-45. PubMed ID: 2985781
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some cardio- or vaso-active butenolide derivatives.
Némoz G; Prigent AF; Picq M; Pacheco H
Biochem Pharmacol; 1982 Nov; 31(21):3353-8. PubMed ID: 6293510
[No Abstract] [Full Text] [Related]
16. Calmodulin-stimulated cyclic nucleotide phosphodiesterase from Neurospora crassa.
Ortega Perez R; Van Tuinen D; Marmé D; Turian G
Biochim Biophys Acta; 1983 Jul; 758(1):84-7. PubMed ID: 6305427
[TBL] [Abstract][Full Text] [Related]
17. The identification of apparently novel cyclic AMP and cyclic GMP phosphodiesterase activities in guinea-pig tracheal smooth muscle.
Burns F; Stevens PA; Pyne NJ
Br J Pharmacol; 1994 Sep; 113(1):3-4. PubMed ID: 7812625
[TBL] [Abstract][Full Text] [Related]
18. [Separation and investigation of the regulatory properties of two forms of cyclic nucleotide phosphodiesterase from rabbit heart--sensitive and insensitive to Ca-dependent regulator protein].
Tkachuk VA; Lazarevich VG; Men'shikov MIu; Severin SE
Biokhimiia; 1978 Sep; 43(9):1622-30. PubMed ID: 214170
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some pentasubstituted quercetin analogs.
Picq M; Prigent AF; Nemoz G; Pacheco H
Biochem Pharmacol; 1982 Sep; 31(17):2777-82. PubMed ID: 6291544
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of rat lung cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase by cyclic nucleotides and their analogues and various drugs [proceedings].
Butt NM; Saeed SA; Collier HO
Biochem Soc Trans; 1980 Jun; 8(3):380-1. PubMed ID: 6249674
[No Abstract] [Full Text] [Related]
[Next] [New Search]
